Author:
Shimoyama Rai,Yasui Hirofumi,Boku Narikazu,Onozawa Yusuke,Hironaka Shuichi,Fukutomi Akira,Yamazaki Kentaro,Taku Keisei,Kojima Takashi,Machida Nozomu,Todaka Akiko,Tomita Hideharu,Sakamoto Takeshi,Tsushima Takahiro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Gastroenterology,Oncology,General Medicine
Reference29 articles.
1. Parki DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
2. Statistics and Information Department, Ministry of Health, Labour and Welfare. Vital statistics in 2007 (in Japanese). http://www.mhlw.go.jp . Accessed 30 April 2009.
3. Pyrhoenen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587–591.
4. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993;72:37–41.
5. Glimelius B, Hoffman K, Haglund U, Nyren O, Sjoeden PO Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 1994;5:189–190.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献